4th ACE DRUG DISCOVERY SUMMIT
2nd - 3rd April, 2025
WEDNESDAY-THURSDAY
The Insurance Hall, London, UK
About 4th ADDS
4th ACE Drug Discovery Summit, 2025 provides a platform for scientists, researchers and decision makers from all over the world to debate on the latest scientific advances, trends, current challenges and futuristic advancements in Drug Discovery. The two day conference is designed to maximize collaborations and innovation with pharma and technology presentations, interactive sessions by professionals from industry and academia. The Summit features talks on the cutting edge of the discipline that include latest scientific advancements in the areas of drug discovery, AI, screening automation, high content imaging, disease modelling, cell and gene therapy and more. Summit will be attracting senior strategic decision-makers with top-level speakers, interactive round-tables, knowledge-sharing panel sessions, in-depth workshops and superb networking. Join us at 4th ACE Drug Discovery, 2025 to meet scientists from around the world and to learn how to move pharma from the bench to the market. We look forward to your contribution!
Why Attend
ADDS Thought Leaders
Soroush Safaei
Senior Principal Scientist
 | Sanofi
Michael Hennig
CEO |
 leadXpro
JOHN NIELAND
CSO |
2N Pharma
ADELE ROWLEY
Chief Scientific Officer |
Mironid
Mark Eccleston
CEO |
VALIRX PLC
SHAYONI DUTTAÂ
Senior Principal Data
Scientist | GSK
Mark Austin
Associate Director |
AstraZeneca
NORMAN MILLER
Cofounder and CSO |
Kutanios Ltd
Asif Ahmed
CEO |
MirZyme Therapeutics
Svetlana Saveljeva
Principal Pharmacologist
| Healx
Duleek Ranatunga
CEO |
PEAR BIO
Bilada Bilican
Senior Director – Applied Stem Cell Sciences | AstraZeneca
John Maher
CSO |
Leucid Bio
Alessandro Bonetti
Director |
AstraZeneca
Annick Sawala
Head of Translational Research
| Vivan Therapeutics
Alejandra Tomas
Head of Section of Cell Biology and Functional Genomics | Imperial College London
Chandan Seth Nanda
Senior Scientist Vice President of Target & Drug Discovery | Pear Bio
Saoirse O’Sullivan
Vice President of Translational Sciences | Artelo Biosciences
Dmitry Veprintsev
Co-Founder & CSO
| Combinate-Tx.AI
Andrew Yates
Chief Scientific Officer | Artelo Biosciences
Myles Osborn
Medicinal Chemistry Lead | Artelo Biosciences
Jordan Abdi
Co-Founder & CEO |
U-Ploid Biotechnologies
ASIF AHMED
Executive Chairman & CEO | MirZyme Therapeutics
SHAYONI DUTTAÂ
Senior principal Data
scientist | GSK
SONA CHANDRAÂ
President, AI
Pangea Bio
BRENDAN SWAIN
CSO
Shift Bioscience Ltd
Solutions at ADDS
🔷 Antibody Engineering
🔷 ADMUPI (Toxicology)
🔷 Covering Biological studies
🔷 Discovery Outsourcing Services
🔷 Drug Discovery Technology Platforms
🔷 High Throughput Screening
🔷 Licensing
🔷 ln licensing/out licensing discovery          projects proprietary technologies
🔷 PK/PD
🔷 Protein identification Services
🔷 Screening and Profiling Services
🔷 Transgenisis Services
🔷 Biochemistry
🔷 Biomarker Validation
🔷 Data Management Technology
🔷 DNA & RNA Analysis
🔷 Gene Expression Profiling Solutions
🔷 Lead Generation
🔷 lmaging/biomarker service/collaboration
🔷 Medicinal Chemistry
🔷 Pharmacogenetic Testing
🔷 Preclinical
🔷 Research & Development
🔷 Structural Biology
🔷 Bio-informatics
🔷 Combinatorial Chemistry
🔷 Digital lmaging Technology
🔷 DNA Sequencing Services
🔷 Genomics
🔷 Lead Optimatisation and Profiling, HTS       Technology
🔷 Molecular Biology
🔷 Pharmacology
🔷 Principal Scientists
🔷 Reagents Technology
🔷 Target identification & Validation
Who Will Attend
🔷 CEO
🔷 Director of Discovery Strategy Portfolio
🔷 Head of DMPK
🔷 Head of R&D Licensing
🔷 Senior Director Discovery Research
🔷 VP of Chemistry
🔷 VP Translational Medicine
🔷 CSO
🔷 Director of Screening & Compound Profiling
🔷 Head of Drug Design
🔷 Head Pharmacology & Toxicology
🔷 Senior Director Function Genomics
🔷 Head Pharmacology & Toxicology
🔷 Director Discovery Alliances
🔷 Executive Director Chemistry
🔷 Head of Molecular Toxicology
🔷 Principal Scientist
🔷 VP & Director of Drug Discovery
🔷 VP Target Discovery & Assessment
Attendee Breakdown
Attendee Demographics
Agenda
🔷 08:45 – 09:00 Chairman’s Welcome Remarks
🔷 09:00 – 09:30 Presentation no.1:
The rise of deep learning in drug discovery:
- The recent applications of deep learning in drug discovery research
- Deep learning methods/tools relevant to research.
- Future development of deep learning in drug discovery
Buyers 2025 Pharma / Biotech
Our Sponsors
Our Partners
Media Partners
Venue - The Insurance Hall, London, UK
Â
The Insurance Hall has been the home of the UK Insurance sector for over 80 years. It is a prestigious and impressive event venue steeped in history, heritage and architectural significance, a hidden gem in one of City of London’s most decorated and prestigious buildings.
A Grade II listed building formally opened by His Majesty King George V in 1934, The Insurance Hall offers exceptional and flexible event spaces for conferences, receptions, AGMs, business breakfasts, meetings, lunches and dinners for up to 300 delegates.
Leonardo Hotel London, UK is the ideal venue for your next conference. The hotel features modern, fully-equipped conference rooms designed to accommodate various event sizes and formats, from intimate meetings to large seminars. Each conference room is outfitted with the latest audiovisual technology, free high-speed Wi-Fi, and comfortable seating arrangements to ensure a productive and seamless experience. Attendees can take advantage of the hotel’s excellent catering services, providing a range of delicious dining options tailored to your event’s needs. Guests will appreciate the stylish, comfortable accommodations, complete with amenities such as soundproof windows, air conditioning, and flat-screen TVs. Situated in the heart of London, the hotel offers easy access to public transport and local attractions, enhancing the overall experience for attendees. With a dedicated events team ready to assist with every detail, Leonardo Hotel London ensures a successful and memorable conference experience.
SPONSORSHIP OPPORTUNITIES
If you wish to inquire about sponsorship prospects, kindly reach out to:
SPEAKER / DELEGATE OPPORTUNITIES
If you wish to inquire about speaking opportunities, and to book attendee pass, kindly reach out to:
